Brain abscess caused by Nocardia cyriacigeorgica in two patients with multiple myeloma: novel agents, new spectrum of infections

Pamukcuoglu M., Emmez H., GÜZEL TUNÇCAN Ö. , ÖNER A. Y. , Cirak M. Y. , ŞENOL E. , ...Daha Fazla

HEMATOLOGY, cilt.19, sa.3, ss.158-162, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Objective and importance: Introduction of high-dose chemotherapy and the novel agents including bortezomib, Lenalidomide, and Thalidomide has provided a significant progress in the treatment of multiple myeloma (MM) with an increase in median overall survival up to 6-8 years. However, the advances in myeloma treatment comes at a price with new spectrum of treatment-related infectious complications which should be taken into consideration while treating these patients.